Eligibility and cost for icosapent ethyl based on the reduce-it trial: Insight from the veterans affairs healthcare system

Xiaoming Jia, Julia M. Akeroyd, Khurram Nasir, Vijay Nambi, Christie M. Ballantyne, Laura A. Petersen, Salim S. Virani

Research output: Contribution to journalLetterpeer-review

17 Citations (Scopus)
Original languageEnglish
Pages (from-to)1341-1343
Number of pages3
JournalCirculation
Volume139
Issue number10
DOIs
Publication statusPublished - 5 Mar 2019
Externally publishedYes

Keywords

  • icosapent ethyl

Cite this